Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ovarian Cancer Risk-Reduction and Screening in BRCA1/2 Mutation Carriers.

Journal of women's health (2002) - 1 May 2024

DiSilvestro Jessica B, Haddad Jessica, Robison Katina, Beffa Lindsey, Laprise Jessica, Scalia-Wilbur Jennifer, Raker Christina, Clark Melissa A, Lokich Elizabeth, Hofstatter Erin, Dalela Disha, Brown Amy, Bradford Leslie, Toland Maris, Stuckey Ashley

Abstract excerpt

Objective: To determine the utilization of risk-reducing strategies and screening protocols for ovarian cancer in female BRCA1/2 carriers. Methods: This study was a sub-analysis of female participants from a larger multicenter, cross-sectional survey of BRCA1/2 mutation carriers unaffected by cancer. The questionnaire was administered electronically via email at four institutions located in the northeast United...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Ovarian Neoplasms

Share to Risk Reduction Behavior

Share to Surveys and Questionnaires

Source

Identifiers

PMID: 38488054
DOI: 10.1089/jwh.2023.0621

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ovarian Cancer Risk-Reduction and Screening in BRCA1/2 Mutation Carriers.PMID 38488054Read ↗

Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.Semantic proximity Read ↗

Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience.Semantic proximity Read ↗

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.Semantic proximity Read ↗

Factors affecting surgical decision-making in carriers of BRCA1/2 pathogenic variants undergoing risk-reducing surgery at a dedicated hereditary ovarian cancer clinic.Semantic proximity Read ↗

Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be done.Semantic proximity Read ↗

Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.Semantic proximity Read ↗

Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.Semantic proximity Read ↗

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.Semantic proximity Read ↗

Risk management options elected by women after testing positive for a BRCA mutation.Semantic proximity Read ↗

Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.Semantic proximity Read ↗

Increasing the Uptake of Cancer Risk Management Strategies for Women With BRCA1/2 Sequence Variations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.